Progyny, Inc. (PGNY)
NASDAQ: PGNY · Real-Time Price · USD
13.98
+0.31 (2.27%)
At close: Nov 20, 2024, 4:00 PM
14.00
+0.02 (0.14%)
Pre-market: Nov 21, 2024, 7:30 AM EST
Progyny Market Cap
Progyny has a market cap or net worth of $1.19 billion as of November 21, 2024. Its market cap has decreased by -61.15% in one year.
Market Cap
1.19B
Enterprise Value
974.22M
1-Year Change
-61.15%
Ranking
Category
Stock Price
$13.98
Market Cap Chart
Since October 25, 2019, Progyny's market cap has decreased from $1.31B to $1.19B, a decrease of -9.12%. That is a compound annual growth rate of -1.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 1.19B | -66.59% |
| Dec 29, 2023 | 3.56B | 23.15% |
| Dec 30, 2022 | 2.89B | -36.45% |
| Dec 31, 2021 | 4.55B | 23.98% |
| Dec 31, 2020 | 3.67B | 59.18% |
| Dec 31, 2019 | 2.31B | 76.13% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enliven Therapeutics | 1.22B |
| Alphatec Holdings | 1.21B |
| Tilray Brands | 1.19B |
| Mesoblast | 1.19B |
| Innoviva | 1.19B |
| Ardelyx | 1.17B |
| CareDx | 1.16B |
| Maravai LifeSciences Holdings | 1.15B |